Skip to content

Clinical trials

Completed Phase 4 Macular Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Phase 4 Status: Completed Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20051
20063
20074
20083
20092
20105
20112
20123
20133
20148
20152
20161
20172
20181
20191
20213
20222
20243
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals12
Novartis3
Bayer2
Formycon AG2
Illinois Retina Associates2
University of California, San Diego2
Vista Klinik2
Augenabteilung Allgemeines Krankenhaus Linz1
Bausch & Lomb Incorporated1
Brandon G. Busbee, MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration52
Choroidal Neovascularization13
Wet Macular Degeneration7
Geographic Atrophy6
Vision Disorders6
Retinal Vein Occlusion5
Diabetic Retinopathy3
Eye Diseases3
Polypoidal Choroidal Vasculopathy3
Retinal Degeneration3

Trials

Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.